Greenwich LifeSciences, Inc.
NASDAQ:GLSI
13.81 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 6.989 | 13.468 | 27.204 | 28.66 | 0.007 | 0.085 | 0 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 6.989 | 13.468 | 27.204 | 28.66 | 0.007 | 0.085 | 0 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Assets
| 6.989 | 13.468 | 27.204 | 28.66 | 0.007 | 0.085 | 0 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0.005 | 0.009 | 0.013 | 0.016 | 0.02 | 0.023 | 0 |
Goodwill and Intangible Assets
| 0.005 | 0.009 | 0.013 | 0.016 | 0.02 | 0.023 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Assets
| 0.005 | 0.009 | 0.013 | 0.016 | 0.02 | 0.023 | 0.027 |
Total Assets
| 6.995 | 13.477 | 27.217 | 28.677 | 0.027 | 0.109 | 0.027 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 0.035 | 0 | 0.221 | 0.711 | 0.73 | 0.278 | 0.161 |
Short Term Debt
| 0 | 0 | 0 | 0 | 0.001 | 0.42 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | -0 | -0.001 | -0.42 | 0 |
Other Current Liabilities
| 0.259 | 0.263 | 0.164 | 0.335 | 0.647 | 0.451 | 0.396 |
Total Current Liabilities
| 0.294 | 0.263 | 0.385 | 1.045 | 1.377 | 0.729 | 0.558 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| -0 | 0 | 0 | 0 | 0 | 9.5 | 8 |
Total Non-Current Liabilities
| -0 | 0 | 0 | 0 | 0 | 9.5 | 8 |
Total Liabilities
| 0.294 | 0.263 | 0.385 | 1.045 | 1.377 | 10.229 | 8.558 |
Equity: | |||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0.002 | 0.002 | 0.005 |
Common Stock
| 0.013 | 0.013 | 0.013 | 0.013 | 0.008 | 0 | 0.001 |
Retained Earnings
| -50.365 | -41.473 | -33.648 | -29.077 | -27.214 | -23.789 | -22.099 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | -0 | -0 | 0 | 0 | -0.001 |
Other Total Stockholders Equity
| 57.052 | 54.674 | 60.466 | 56.695 | 25.853 | 13.666 | 13.563 |
Total Shareholders Equity
| 6.7 | 13.214 | 26.832 | 27.631 | -1.35 | -10.12 | -8.53 |
Total Equity
| 6.7 | 13.214 | 26.832 | 27.631 | -1.35 | -10.12 | -8.53 |
Total Liabilities & Shareholders Equity
| 6.995 | 13.477 | 27.217 | 28.677 | 0.027 | 0.109 | 0.027 |